| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.006 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.008 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.009 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |